Cardiology - Cardiology Xagena

CardiologyOnline

News

Drugs

Xagena Medicine

Xagena.net

Patients with ADHF: Natrecor increases the risk of worsening renal function

Heart failure: BNP is a strong prognostic marker

Tekturna: a novel renin inhibitor in hypertension

Risk of heart failure increased from Vitamin-E

Myocardial infarction: addition of Plavix to Aspirin and fibrinolytic therapy proves beneficial

Cypher and Taxus, comparable efficacy in preventing in-segment binary restenosis

Hypertension: dietary fiber intake reduces blood pressure

FDA: Crestor has a favorable risk/benefit ratio

FDA has approved Atacand for the treatment of heart failure

Strong evidence for treatment of systolic hypertension in older patients with SBP of at least 160 mm Hg

Zocor did not achieve the prespecified end point in A to Z study - phase Z

Angina pectoris: addition of Nifedipine GITS to conventional treatment has no effect on major cardiovascular event-free survival

Next Pages «

Link

• Allergology

• Biomedicine

• Dermatology

• Diabetology

• Diagnostics

• Endocrinology

• Gastroenterology

• Gene Medicine

• Infectivology

• Ophthalmology

• Pharmacology

• Rheumatology

• Stem Therapy

n Xagena.it

Powered by Luca Malattia - LM Web Solutions